🇺🇸 FDA
Patent

US 10064844

Pharmaceutical compositions comprising an aromatse inhibitors

granted A61KA61K31/4196A61K9/4833

Quick answer

US patent 10064844 (Pharmaceutical compositions comprising an aromatse inhibitors) held by MEREO BIOPHARMA 2 LIMITED expires Mon Aug 30 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
MEREO BIOPHARMA 2 LIMITED
Grant date
Tue Sep 04 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 30 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
17
CPC classes
A61K, A61K31/4196, A61K9/4833, A61K9/485, A61K9/4858